comparemela.com
Home
Live Updates
An Intriguing Failure in Advanced, Pre-Treated GIST : comparemela.com
An 'Intriguing Failure' in Advanced, Pre-Treated GIST
Second-line ripretinib unable to best sunitinib, but still had meaningful clinical activity
Related Keywords
Boston ,
Massachusetts ,
United States ,
Oregon ,
Dana Farber Cancer Institute ,
American ,
Vicki Keedy ,
Michael Heinrich ,
Mike Bassett ,
Ripretinib Qinlock ,
Vanderbilt University Medical Center ,
American Society Of Clinical Oncology ,
Oregon Health ,
Science University Knight Cancer Institute ,
American Society ,
Clinical Oncology ,
Virtual Plenary ,
George Demetri ,
comparemela.com © 2020. All Rights Reserved.